Codexis, inc. (CDXS)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Revenue sharing arrangement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

445

658

722

773

1,066

1,465

1,525

1,681

1,546

2,128

1,943

2,331

839

417

1,044

0

0

0

250

-

-

-

-

-

-

Related party collaborative research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,653

Government awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

632

258

1,357

705

1,882

273

616

379

492

Total revenues

14,670

18,650

21,906

12,319

15,583

16,068

16,946

13,538

14,042

21,722

9,984

10,347

7,971

9,969

14,870

16,002

7,996

11,587

17,401

6,018

6,798

14,191

7,472

6,570

7,074

9,525

3,943

6,974

11,481

7,912

26,341

22,909

31,136

33,494

33,282

26,055

31,034

27,113

24,480

Costs and operating expenses:
Cost of product revenue

2,541

3,402

5,067

2,772

4,391

2,393

3,791

2,611

3,825

3,559

3,976

3,790

3,002

2,287

2,756

2,221

2,489

2,578

1,302

1,250

1,456

3,547

1,532

2,123

2,524

4,764

494

3,631

5,665

5,779

6,397

5,829

12,642

13,067

9,958

7,106

11,650

8,563

6,075

Research and development

10,967

8,872

8,711

8,274

8,016

7,513

7,917

7,370

7,178

9,417

8,055

6,348

5,839

5,964

5,467

5,112

5,686

5,216

4,994

5,170

5,293

5,150

5,038

7,733

4,834

8,829

6,831

8,624

7,322

10,594

14,191

15,650

16,349

15,548

16,786

14,965

13,750

13,070

13,004

Selling, general and administrative

8,989

7,322

7,869

7,896

8,415

6,806

7,344

7,395

7,746

7,867

7,989

6,546

6,606

6,968

5,229

6,420

6,802

6,026

5,415

5,296

5,578

5,043

5,157

5,625

6,112

5,783

5,832

7,169

8,124

7,286

7,909

6,789

9,395

9,782

8,871

9,276

9,013

7,940

8,652

Total costs and operating expenses

22,497

19,596

21,647

18,942

20,822

16,712

19,052

17,376

18,749

20,843

20,020

16,684

15,447

15,219

13,452

13,753

14,977

13,820

11,711

11,716

12,327

13,740

11,727

15,481

13,470

19,376

13,157

19,424

21,111

23,659

28,497

28,268

38,386

38,397

35,615

31,347

34,413

29,573

27,731

Loss from operations

-7,827

-946

259

-6,623

-5,239

-644

-2,106

-3,838

-4,707

879

-10,036

-6,337

-7,476

-5,250

1,418

2,249

-6,981

-2,233

5,690

-5,698

-5,529

451

-4,255

-8,911

-6,396

-9,852

-9,214

-12,450

-9,630

-

-

-

-

-

-

-

-

-2,460

-3,251

Interest income

266

356

480

220

231

227

199

174

71

52

28

49

18

20

12

13

15

7

4

4

4

3

3

3

9

8

9

16

27

-

-

-

-

-

-

-

-

61

46

Other expenses, net

-86

-40

-403

-88

-125

-69

-80

-82

-60

-12

-68

-34

22

-55

7

-49

3

315

-26

-96

-25

51

57

8

118

14

22

183

85

-

-

-

-

-

-

-

-

35

654

Loss before income taxes

-7,647

-630

336

-6,491

-5,133

-486

-1,987

-3,746

-4,696

919

-10,076

-6,322

-7,436

-5,285

1,437

2,213

-6,963

-2,247

5,668

-5,790

-5,550

403

-4,309

-8,916

-6,505

-9,858

-9,227

-12,617

-9,688

-15,711

-2,140

-5,442

-7,293

-5,123

-2,668

-5,205

-3,313

-2,434

-3,859

Provision for income taxes

5

5

-7

16

3

-25

1

-11

-2

-51

150

-42

24

-25

0

-26

11

-194

274

-430

12

58

253

-437

-130

-45

35

-12

-65

-

-

-

-

-

-

-

-

298

87

Net loss

-7,652

-635

343

-6,507

-5,136

-461

-1,988

-3,735

-4,694

970

-10,226

-6,280

-7,460

-5,260

1,437

2,239

-6,974

-2,053

5,394

-5,360

-5,562

345

-4,562

-8,479

-6,375

-9,813

-9,262

-12,605

-9,623

-15,538

-2,309

-5,519

-7,490

-5,297

-2,742

-5,040

-3,471

-2,732

-3,946

Net loss per share, basic and diluted (usd per share)

-0.13

-

-

-0.12

-0.09

-

-

-0.07

-0.10

0.02

-0.21

-0.13

-0.18

-

-

-

-0.17

-

-

-

-0.14

-

-

-0.22

-0.17

-0.26

-0.24

-0.33

-0.25

-0.41

-0.06

-0.15

-0.21

-0.15

-0.08

-0.14

-0.10

-0.08

-0.15

Weighted average common stock shares used in computing net loss per share, basic and diluted (shares)

58,888

-

-

54,954

54,170

-

-

52,787

48,385

48,283

48,147

47,232

41,250

-

-

-

40,072

-

-

-

38,779

-

-

37,980

38,506

38,329

38,102

38,060

37,842

37,581

37,118

36,296

36,057

35,965

35,919

35,685

35,116

34,200

26,557

Net income (loss) per share, basic (usd per share)

-

-

0.01

-

-

-

-0.04

-

-

-

-

-

-

-

0.04

0.06

-

-

0.14

-0.14

-

-

-0.12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) per share, diluted (usd per share)

-

-

0.01

-

-

-

-0.04

-

-

-

-

-

-

-

0.03

0.05

-

-

0.13

-0.14

-

-

-0.12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common stock shares used in computing net income (loss) per share, basic (shares)

-

-

58,287

-

-

-

53,597

-

-

-

-

-

-

-

40,940

40,495

-

-

39,767

39,301

-

-

38,450

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common stock shares used in computing net income (loss) per share, diluted (shares)

-

-

61,412

-

-

-

53,597

-

-

-

-

-

-

-

42,134

41,568

-

-

40,970

39,301

-

-

38,450

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product Sales [Member]
Total revenues

5,100

4,877

10,351

6,249

7,988

7,299

8,405

3,723

6,163

7,551

6,948

6,600

5,586

4,249

4,052

3,280

3,740

4,462

1,818

2,020

3,076

4,741

2,562

2,776

2,985

5,263

1,076

4,948

9,137

6,834

7,140

6,783

15,167

15,493

12,199

8,397

12,932

9,491

8,484

Research and Development Revenue [Member]
Total revenues

9,570

13,773

11,555

6,070

7,595

8,769

8,541

9,815

7,879

14,171

3,036

3,747

2,385

7,545

10,373

12,064

3,534

6,352

14,517

2,533

2,197

7,769

3,364

1,666

2,146

1,931

2,028

1,609

1,300

1,078

18,569

15,868

14,362

17,296

19,201

17,385

17,486

17,243

851